Time Tested Since 1971
Cart 0

Winter 2019 New & Updated IV Compatibility & Stability

In this supplement we added a new drug monograph for LEVOSIMENDAN, NATALIZUMAB, NIVOLUMAB, NUSINERSEN, OCRELIZUMAB, OMADACYCLINE, PEMBROLIZUMAB, and VEDOLIZUMAB.

We added new stability information to these existing drug monographs: AMIFOSTINE, AMINOPHYLLINE, BUPIVACAINE HYDROCHLORIDE, CARBOPLATIN, CHLORAMPHENICOL SODIUM SUCCINATE, CEFOTETAN DISODIUM, CORTICOTROPIN, TRASTUZUMAB, and VALPROATE SODIUM.

In addition, new compatibility information is reported for these drugs: DOBUTAMINE HYDROCHLORIDE, DOPAMINE HYDROCHLORIDE, EPINEPHRINE HYDROCHLORIDE, FENTANYL CITRATE, MIDAZOLAM HYDROCHLORIDE, MILRINONE LACTATE, NITROGLYCERINE, NITROPRUSSIDE SODIUM, NOREPINEPHRINE BITARTRATE, REMIFENTANIL HYDROCHLORIDE, ROCURONIUM BROMIDE, SODIUM THIOSULFATE, VASOPRESSIN, and VECURONIUM BROMIDE.



Older Post Newer Post